Cargando…
Tyrosine kinase inhibitors and mesenchymal stromal cells: effects on self-renewal, commitment and functions
The hope of selectively targeting cancer cells by therapy and eradicating definitively malignancies is based on the identification of pathways or metabolisms that clearly distinguish “normal” from “transformed” phenotypes. Some tyrosine kinase activities, specifically unregulated and potently activa...
Autores principales: | Borriello, Adriana, Caldarelli, Ilaria, Bencivenga, Debora, Stampone, Emanuela, Perrotta, Silverio, Oliva, Adriana, Ragione, Fulvio Della |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354929/ https://www.ncbi.nlm.nih.gov/pubmed/27750212 http://dx.doi.org/10.18632/oncotarget.12649 |
Ejemplares similares
-
The Tyrosine Kinase Inhibitor Dasatinib Induces a Marked Adipogenic Differentiation of Human Multipotent Mesenchymal Stromal Cells
por: Borriello, Adriana, et al.
Publicado: (2011) -
Genetic and Epigenetic Control of CDKN1C Expression: Importance in Cell Commitment and Differentiation, Tissue Homeostasis and Human Diseases
por: Stampone, Emanuela, et al.
Publicado: (2018) -
p27(Kip1), an Intrinsically Unstructured Protein with Scaffold Properties
por: Bencivenga, Debora, et al.
Publicado: (2021) -
Genome editing and cancer therapy: handling the hypoxia-responsive pathway as a promising strategy
por: Stampone, Emanuela, et al.
Publicado: (2023) -
An Unanticipated Modulation of Cyclin-Dependent Kinase Inhibitors: The Role of Long Non-Coding RNAs
por: Bencivenga, Debora, et al.
Publicado: (2022)